Benzinga··Vandana SinghMerck Bets $838M on Infinimmune's AI-Powered Antibody Platform
Merck partners with Infinimmune for next-gen antibody drugs, gaining exclusive rights to candidates from AI-powered platform with up to $838M in potential milestone payments.
MRKTERNbiotech partnershipmachine learning